CCRM in the News 2022

A sampling of media coverage that profiles or mentions CCRM

Canada aims to get a slice of the growing global market for cell and gene therapies. Toronto Star, May 18, 2022.

Federal investment required to build a cell and gene therapy ecosystem in Canada, says Innovation Economy Council. Research Money, May 10, 2022.

AcCELLerate-ON awards $900K to four projects that put Canadian cellular agriculture on the map. Food Matters Live, May 6, 2022.

What’s a CDMO and why do biotech startups need them? Let’s ask Canada. Crunchbase News, May 5. 2022.

Healthcare Is a Cost. But It’s Also a Business Opportunity. Canadian Business, April 26, 2022.

Tech update: Using artificial intelligence to solve supply chain snarls, and consolidation in Canadian crypto. The Peterborough Examiner, April 22, 2022.

Canada should be manufacturing its own cell and gene therapies, not just vaccines. The Globe and Mail, April 11, 2022.

Ontario antes up $580M for C&G therapy plant in Hamilton. Endpoints News, April 1, 2022.

Gene therapy manufacturing coming to McMaster Innovation Park. The Bay Observer, April 1, 2022.

Ontario invests in $580 million gene and cell therapy facility in Hamilton. CHCH-TV, March 31, 2022.

New gene- and cell-therapy manufacturing facility to launch in Hamilton with $580-million commitment. The Globe and Mail, March 31, 2022.

WATCH: Ontario economic development minister to make announcement in Hamilton at 1:30 p.m. CHCH-TV, March 31, 2022.

How Sherif Sheta leads IT to keep Canada on life sciences’ cutting edge. CIO, February 24, 2022.

Canada’s Biomanufacturing Workforce. Manufacturing in Focus, February, 2022.

Hamilton needs manufacturing mojo. The Hamilton Spectator, February 13, 2022.

News pages contact

If you are a member of the media, please contact stacey.johnson@ccrm.ca.
Font Resize
Enable Contrast